Evolent Health (NYSE:EVH) Hits New 52-Week Low - What's Next?

Evolent Health, Inc. (NYSE:EVH - Get Free Report) shares hit a new 52-week low during trading on Thursday . The stock traded as low as $9.74 and last traded at $9.79, with a volume of 2041320 shares trading hands. The stock had previously closed at $10.37.

Analysts Set New Price Targets

EVH has been the topic of a number of research analyst reports. Stephens reduced their target price on Evolent Health from $16.00 to $12.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 21st. Oppenheimer dropped their price objective on Evolent Health from $28.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. JPMorgan Chase & Co. decreased their target price on Evolent Health from $15.00 to $13.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Barclays dropped their target price on shares of Evolent Health from $39.00 to $19.00 and set an "overweight" rating for the company in a report on Monday, November 11th. Finally, UBS Group decreased their price target on shares of Evolent Health from $27.00 to $14.00 and set a "buy" rating on the stock in a report on Thursday, January 16th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $18.38.

Evolent Health Trading Up 0.4 %

The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $1.15 billion, a price-to-earnings ratio of -10.86 and a beta of 1.45. The business's fifty day moving average price is $10.99 and its 200 day moving average price is $19.60.

Evolent Health (NYSE:EVH - Get Free Report) last announced its earnings results on Thursday, November 7th. The technology company reported ($0.08) EPS for the quarter, missing the consensus estimate of $0.30 by ($0.38). The company had revenue of $621.40 million for the quarter, compared to analyst estimates of $625.58 million. Evolent Health had a positive return on equity of 6.30% and a negative net margin of 2.93%. During the same period in the previous year, the firm posted $0.19 earnings per share. Research analysts anticipate that Evolent Health, Inc. will post 0.22 earnings per share for the current fiscal year.

Institutional Trading of Evolent Health

Institutional investors have recently added to or reduced their stakes in the stock. R Squared Ltd bought a new position in Evolent Health during the 4th quarter worth approximately $31,000. AlphaQuest LLC boosted its position in Evolent Health by 21,650.0% during the fourth quarter. AlphaQuest LLC now owns 3,045 shares of the technology company's stock valued at $34,000 after acquiring an additional 3,031 shares during the last quarter. Covestor Ltd grew its holdings in Evolent Health by 138.1% during the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company's stock worth $40,000 after acquiring an additional 826 shares during the period. GAMMA Investing LLC raised its position in shares of Evolent Health by 5,365.5% in the 3rd quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company's stock worth $45,000 after acquiring an additional 1,556 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in shares of Evolent Health by 90.7% in the 4th quarter. Parkside Financial Bank & Trust now owns 4,957 shares of the technology company's stock valued at $56,000 after purchasing an additional 2,358 shares during the period.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.